These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 5066229)
21. Effects of amantadine hydrochloride on catecholamine metabolism in the brain of the rat. Baldessarini RJ; Lipinski JF; Chace KV Biochem Pharmacol; 1972 Jan; 21(1):77-87. PubMed ID: 5058704 [No Abstract] [Full Text] [Related]
22. Interactions between monoamine oxidase inhibitors and sympathomimetic amines in the rat isolated vas deferens. Laporte J; Jané F; Valdecasas FG J Pharm Pharmacol; 1968 Feb; 20(2):148-9. PubMed ID: 4384539 [No Abstract] [Full Text] [Related]
23. [Cardiac noradrenaline and tyramine hypertension]. Beauvallet M; Cahen R; Fugazza J; Godefroy F C R Seances Soc Biol Fil; 1969 Feb; 162(7):1328-31. PubMed ID: 4238879 [No Abstract] [Full Text] [Related]
24. The influence of intraneuronal monoamine oxidase on neuronal net uptake of noradrenaline and on sensitivity to noradrenaline. Trendelenburg U; Draskóczy PR; Graefe KH Adv Biochem Psychopharmacol; 1972; 5():371-7. PubMed ID: 5054208 [No Abstract] [Full Text] [Related]
25. Relationship between tyramine potentiation and selective inhibition of monoamine oxidase types A and B in the rat vas deferens. Finberg JP; Tenne M Br J Pharmacol; 1982 Sep; 77(1):13-21. PubMed ID: 6127132 [TBL] [Abstract][Full Text] [Related]
26. Effects of inhibition of monoamine oxidase on the actions and interactions of norepinephrine, tyramine and other drugs on guinea-pig left atrium. Furchgott RF; Sanchez Garcia P J Pharmacol Exp Ther; 1968 Sep; 163(1):98-122. PubMed ID: 5673720 [No Abstract] [Full Text] [Related]
27. MAO-A and MAO-B in the superior cervical ganglion and in the nictitating membrane of the cat. Filinger EJ; Stefano FJ Gen Pharmacol; 1981; 12(6):481-4. PubMed ID: 7308736 [No Abstract] [Full Text] [Related]
28. Some direct and indirect sympathomimetic actions of metaraminol. Stone CA; Stavorski JM; Ludden CT; Wenger HC; Torchiana ML Arch Int Pharmacodyn Ther; 1966 May; 161(1):49-60. PubMed ID: 5941882 [No Abstract] [Full Text] [Related]
29. Auto-potentiation and potentiation by inhibition of monoamine oxidase of the sympathomimetic action of phenelzine and pheniprazine. Clineschmidt V; Horita A Br J Pharmacol Chemother; 1967 May; 30(1):67-77. PubMed ID: 4382676 [No Abstract] [Full Text] [Related]
31. The role of bioactivation on the pharmacology of the potent monoamine oxidase inhibitor 5-oxo-N-(D-trans-2-phenylcyclopropyl)-L-2-pyrrolidine-carboxamide (EX-4883). Lowe MC; Horita A Proc West Pharmacol Soc; 1969; 12():87. PubMed ID: 5812307 [No Abstract] [Full Text] [Related]
32. [On the pharmacology of N-(2-guanidinoethyl)-4-methyl-1,2,3,6-tetrahydropyridine, a new antihypertensive-acting compound]. Kroneberg G; Schlossmann K; Stoepel K Arzneimittelforschung; 1967 Feb; 17(2):199-207. PubMed ID: 5631784 [No Abstract] [Full Text] [Related]
33. A comparative study of the noradrenaline-depleting and sympathetic-blocking actions of guanethidine and (-)-beta-hydroxyphenethylguanidine. Fielden R; Green AL Br J Pharmacol Chemother; 1967 May; 30(1):155-65. PubMed ID: 6039969 [No Abstract] [Full Text] [Related]
35. A use of the isomeric ratio as a criterion to differentiate adrenergic receptors. Patil PN J Pharm Pharmacol; 1969 Sep; 21(9):628-9. PubMed ID: 4390348 [No Abstract] [Full Text] [Related]